Sort
30,917 grants matching “tumor microenvironment”
MUC1-C is a target for advancing immunotherapy of non-small cell lung cancer
$450,429Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2024 · CA
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
$450,386Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
$450,386Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
$450,366Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade
$450,319Craig Lewis Duvall · Vanderbilt University · R01 · FY2021 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade
$450,319Craig Lewis Duvall · Vanderbilt University · R01 · FY2020 · CA
Overcoming ibrutinib resistance in mantle cell lymphoma
$450,309Alexey V. Danilov · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Development of Angiogenesis Inhibitors
$450,217William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma
$450,013David Sidransky · Johns Hopkins University · R01 · FY2024 · CA
Elucidating protective CTL immunity through physical detection of epitopes in conjunction with assessment of TCR-pMHC bond lifetimes under load
$450,000Ellis L Reinherz · Dana-Farber Cancer Inst · R56 · FY2017 · AI
EPIGENETIC IMPACT OF BREAST TUMORS MICROENVIRONMENT ON NORMAL MAMMARY STEM CELLS: A NOVEL APPROACH FOR DEVELOPING TREATMENT REGIMENS AND DIAGNOSTIC T
$450,000Ohio State University Research Foundation, The · · FY2008 · Department of the Army
Bone Microenvironment Contributions to Metastatic Disease
$449,984David T Scadden · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
MITF: Regulating Osteoclast Gene Expression and Function
$449,932Michael C Ostrowski · Medical University Of South Carolina · R01 · FY2019 · AR
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
$449,910Maninder Sandey · Auburn University At Auburn · R15 · FY2023 · CA
UNS: Three Dimensional Microengineered Diseased Tissue Model to Study Invasive Phenotype of Cancer Cells
$449,884Mehdi Nikkhah · Arizona State University · · FY2015 · ENG
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$449,825Melissa B Davis · Morehouse School Of Medicine · R01 · FY2024 · CA
Duke-UNC Chapel Hill Immunotherapy Training Grant
$449,807Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2018 · CA
Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma
$449,805Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R01 · FY2023 · CA
The Role of Hematopoietic Stem and Progenitor Cells in Solid Tumor Growth and Response to Radiation Therapy
$449,795Gerard James Madlambayan · Oakland University · R15 · FY2022 · CA
Developmental studies to inform clinical stratification and targeting of SHH MB
$449,790Alexandra L. Joyner · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Targeting autophagy to enhance immune checkpoint inhibition
$449,729Ravi K Amaravadi · Wistar Institute · P50 · FY2023 · CA
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer
$449,713David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Exosomes in tumor cell-mesenchymal stromal cell interaction
$449,691Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2018 · CA
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$449,580Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2015 · CA
Functional Analysis of Cancer Genes from Human Chromosome 3p
$449,562Michael Lerman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA